Free Trial

Crinetics Pharmaceuticals (CRNX) Earnings Date, Estimates & Call Transcripts

Crinetics Pharmaceuticals logo
$55.96
+0.20 (+0.36%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 12
After Market Closes
Confirmed
Actual EPS
(Aug. 8)
-$0.94 Missed By -$0.08
Consensus EPS
(Aug. 8)
-$0.86
Skip Charts & View Estimated and Actual Earnings Data

CRNX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRNX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Crinetics Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)($0.68)($0.76)
Q2 20242($0.86)($0.71)($0.79)
Q3 20242($0.90)($0.74)($0.82)
Q4 20242($0.90)($0.77)($0.84)
FY 20248($3.50)($2.90)($3.20)
Q3 20251($1.01)($1.01)($1.01)
Q4 20251($1.02)($1.02)($1.02)

CRNX Earnings Date and Information

Crinetics Pharmaceuticals last announced its quarterly earnings results on August 8th, 2024. The reported ($0.94) earnings per share for the quarter, missing analysts' consensus estimates of ($0.86) by $0.08. The company had revenue of $0.40 million for the quarter, compared to the consensus estimate of $0.47 million. Its revenue for the quarter was down 59.6% on a year-over-year basis. Crinetics Pharmaceuticals has generated ($3.78) earnings per share over the last year (($3.78) diluted earnings per share). Earnings for Crinetics Pharmaceuticals are expected to decrease in the coming year, from ($3.72) to ($3.86) per share. Crinetics Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, November 12th, 2024. Crinetics Pharmaceuticals will be holding an earnings conference call on Tuesday, November 12th at 4:30 PM Eastern. Interested parties can register for or listen to the call..

Crinetics Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/12/2024
(Confirmed)
-------  
8/8/2024Q2 2024($0.86)($0.94)($0.08)($0.94)$0.47 million$0.40 million      
5/9/2024Q1 2024($0.84)($0.93)($0.09)($0.93)$0.20 million$0.64 million      
2/28/2024Q4 2023($0.89)($0.90)($0.01)($0.90)$0.20 million-      
11/7/2023Q3 2023($0.89)($1.01)($0.12)($1.01)-$0.35 million  
8/8/2023Q2 2023($0.85)($0.94)($0.09)($0.94)$5.00 million$0.99 million
5/4/2023Q1 2023($0.82)($0.85)($0.03)($0.85)$0.63 million$2.68 million
2/28/2023Q4 2022($0.82)($0.84)($0.02)($0.84)$0.75 million$0.71 million
11/14/2022Q3 2022($0.78)($0.78)-($0.78)$1.00 million$0.46 million
8/12/2022Q2 2022($0.62)($0.81)($0.19)($0.81)$1.80 million$0.44 million
5/12/2022Q1 2022($0.56)($0.73)($0.17)($0.73)-$3.13 million
3/30/2022Q4 2021($0.57)($0.68)($0.11)($0.68)-$1.08 million
11/5/2021Q3 2021($0.72)($0.73)($0.01)($0.73)--
8/9/2021Q2 2021($0.61)($0.70)($0.09)($0.70)--
5/6/2021Q1 2021($0.66)($0.69)($0.03)($0.69)--  
3/29/2021Q4 2020($0.58)($0.66)($0.08)($0.66)--  
11/11/2020Q3 2020($0.53)($0.56)($0.03)($0.56)--
8/7/2020Q2 2020($0.55)($0.53)+$0.02($0.53)--
5/8/2020Q1 2020($0.63)($0.71)($0.08)($0.71)-$0.07 million
3/9/2020Q4 2019($0.68)($0.60)+$0.08($0.60)$0.30 million$0.32 million
11/12/2019Q3 2019($0.5680)($0.60)($0.0320)($0.60)$0.33 million$0.51 million

Crinetics Pharmaceuticals Earnings - Frequently Asked Questions

When is Crinetics Pharmaceuticals's earnings date?

Crinetics Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, November 12th, 2024. Learn more on CRNX's earnings history.

Did Crinetics Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Crinetics Pharmaceuticals (NASDAQ:CRNX) missed the analysts' consensus estimate of ($0.86) by $0.08 with a reported earnings per share (EPS) of ($0.94). Learn more on analysts' earnings estimate vs. CRNX's actual earnings.

How can I listen to Crinetics Pharmaceuticals's earnings conference call?

The conference call for Crinetics Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call

How can I read Crinetics Pharmaceuticals's conference call transcript?

The conference call transcript for Crinetics Pharmaceuticals's latest earnings report can be read online. Read Transcript

How much revenue does Crinetics Pharmaceuticals generate each year?

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded annual revenue of $1.39 million.

How much profit does Crinetics Pharmaceuticals generate each year?

Crinetics Pharmaceuticals (NASDAQ:CRNX) has a recorded net income of -$214.53 million. CRNX has generated -$3.78 earnings per share over the last four quarters.

What is Crinetics Pharmaceuticals's EPS forecast for next year?

Crinetics Pharmaceuticals's earnings are expected to decrease from ($3.72) per share to ($3.86) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:CRNX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners